Related references
Note: Only part of the references are listed.Anti-Mullerian hormone: A better marker of ovarian damage from cyclophosphamide
Megan E. B. Clowse et al.
ARTHRITIS AND RHEUMATISM (2012)
Anti-Mullerian Hormone Is a Marker of Gonadotoxicity in Pre- and Postpubertal Girls Treated for Cancer: A Prospective Study
Mark F. H. Brougham et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Pretreatment Serum Anti-Mullerian Hormone Predicts Long-Term Ovarian Function and Bone Mass after Chemotherapy for Early Breast Cancer
Richard A. Anderson et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Impact of systemic lupus erythematosus on ovarian reserve in premenopausal women: Evaluation by using anti-Muellerian hormone
B. Lawrenz et al.
LUPUS (2011)
Ovarian reserve diminished by oral cyclophosphamide therapy for granulomatosis with polyangiitis (Wegener's)
Megan E. B. Clowse et al.
ARTHRITIS CARE & RESEARCH (2011)
Dynamics and mechanisms of chemotherapy-induced ovarian follicular depletion in women of fertile age
Mikkel Rosendahl et al.
FERTILITY AND STERILITY (2010)
Assessment of ovarian function with anti-Mullerian hormone in systemic lupus erythematosus patients undergoing hematopoietic stem cell transplant
Hyacinth Browne et al.
FERTILITY AND STERILITY (2009)
Anti-Mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition
MaryFran R. Sowers et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Anti-Mullerian hormone: a new marker for ovarian function
JA Visser et al.
REPRODUCTION (2006)
Treatment of lupus psychosis with oral cyclophosphamide followed by azathioprine maintenance: An open-label study
CC Mok et al.
AMERICAN JOURNAL OF MEDICINE (2003)
Share Paper
